Weekly Recap | VG Value -1.62%, trailing the S&P 500 by over a point
I'm LongbridgeAI, I can summarize articles.VTV.US closed the week at $217.23, down 1.62% from the prior Friday, while the S&P 500 slipped only 0.27%. The gap of roughly 1.35 percentage points marks a clear underperformance week for the value-oriented fund. The daily bars show a choppy, slightly downward drift: Monday opened at 219.04 and briefly touched 219.245, then the ETF slid through midweek before hitting the week’s low of 214.80 on Thursday, bouncing modestly to 217.23 on Friday. Trading stayed orderly with a 2.
The Week
VTV.US closed the week at $217.23, down 1.62% from the prior Friday, while the S&P 500 slipped only 0.27%. The gap of roughly 1.35 percentage points marks a clear underperformance week for the value-oriented fund. The daily bars show a choppy, slightly downward drift: Monday opened at 219.04 and briefly touched 219.245, then the ETF slid through midweek before hitting the week’s low of 214.80 on Thursday, bouncing modestly to 217.23 on Friday. Trading stayed orderly with a 2.03% intraweek range, and Thursday’s low also matched the 60-day range floor, pointing to mild profit-taking pressure into quarter-end.
Sector News
Healthcare and financials dominated the news flow inside the value basket. Johnson & Johnson and AbbVie pushed out a heavy stream of clinical updates: J&J highlighted two-year data for ICOTYDE in psoriasis, while AbbVie reported eczema and obesity candidate data plus longer-term Rinvoq vitiligo results. On the financial side, Bank of America added AI tools to its AskGPS and CashPro platforms, Merrill Lynch settled a cash sweep case for $39 million, and a JPMorgan dealmaker announced plans to retire at end-2026. Energy and retail were more mixed—Chevron outperformed peers on a strong trading day, while Walmart drew attention for product recalls and a Mizuho price-target cut. Overall, the tone was supportive for healthcare while financials and energy stayed split.
The Week Ahead
The macro calendar turns to data checks next week. Monday brings the final S&P Global services PMI and ISM non-manufacturing PMI; ISM is forecast to ease to 55 from 55.4, so a weaker print could revive the defensive-value debate. Tuesday’s international trade and goods trade balance figures, with the trade deficit expected to widen to -102 from -88.6, may add pressure on the dollar-sensitive value trade. Wednesday’s EIA crude and Cushing inventory updates could move energy-heavy positioning within the fund. On the corporate side, any follow-through from this week’s large pharma licensing deal headlines is worth watching for healthcare weights.
In Short
The week’s price signal for VTV.US leaned soft—underperforming the S&P 500 and briefly testing its 60-day low, though without any panic-style volume. Valuation sits at 22.91x P/E and 2.30x price-to-book, while the latest session’s large-lot flow turned net seller. That leaves a live tension: positive healthcare data against a wobbly macro backdrop. The next trigger is likely the ISM services print and EIA inventory data; if growth signals weaken, the defensive, value tilt may get another look.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.